beta

AKAO

Achaogen Inc.

Akao

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Achaogen Inc is a biopharmaceutical company committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections.

Market Cap: 468 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.achaogen.com

Shares Outstanding: 42.4 Million

Float: 36.4 Million

Dividend: 0.0 (0.0%)

Beta: 1.259079

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1082 trading days

From: 2017-03-10 To: 2019-04-25

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud